ELAVL1 and metabolic dysfunction-associated steatotic liver disease: Several studies have also identified hepatic HuR as a key player in NAFLD progression through its regulation of lipid and glucose metabolism, modulation of lipid transport, and suppression of adipogenesis [28–30].